the 3rd quarter ended 30 September 2019 Attn: Director and Manager, The Stock Exchange of Thailand With respect to the financial information for the 3rd quarter ended 30 September 2019, as submitted by
www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the
Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the Third quarter of 2019 at the end of 30th September 2019 as
- Translation - 11 November 2019 Subject: Management’s Discussion and Analysis for the Operating Results of the 3 rd Quarter of 2019 Attention: The President of the Stock Exchange of Thailand Exotic
Microsoft Word - MD_A_Q3_2019_EN 1 GLOCON.061/2019 November 11th, 2019 Subject Management’s analysis for the 3rd quarter of 2019 Attn. The President The Stock Exchange of Thailand Management’s
(Ending September 30, 2019) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial for Q3
No. CC20191103ELE November 12, 2019 Re: Clarification of the changes in operation performance for the third quarter and the nine- month period ended 30 September 2019 Attn: The President The Stock
GUIDELINES FRC Investor Listing Standards Proposal: Recommendations for Stock Exchange CERES ผู้ประกอบวิชาชีพ/ Gatekeepe r เรื่อง หน่วยงาน Corporate Secretaries เลขานุการบริษัท CSIA แนวปฏิบัติการ
Page 1 of 3 No. ACC6308/001 August 11, 2021 Subject: Clarification of the operating results quarter 2/2021 of the year ended June 30, 2021 Attention : Director and Managing Director, The Stock
Page 1 of 3 No. ACC6411/003 November 11, 2021 Subject: Clarification of the operating results quarter 3/2021 of the year ended September 30, 2021 Attention : Director and Managing Director, The Stock